Loss of the RNA trimethylguanosine cap is compatible with nuclear accumulation of spliceosomal snRNAs but not pre-mRNA splicing or snRNA processing during animal development
Authors:
Lin Cheng aff001; Yu Zhang aff003; Yi Zhang aff005; Tao Chen aff001; Yong-Zhen Xu aff004; Yikang S. Rong aff002
Authors place of work:
School of Life Sciences, Sun Yat-sen University, Guangzhou, China
aff001; Hengyang College of Medicine, University of South China, Hengyang, China
aff002; Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China
aff003; College of Life Sciences, Wuhan University, Wuhan, China
aff004; Laboratory of Biochemistry and Molecular Biology, National Cancer Institute, Bethesda, United States of America
aff005
Published in the journal:
Loss of the RNA trimethylguanosine cap is compatible with nuclear accumulation of spliceosomal snRNAs but not pre-mRNA splicing or snRNA processing during animal development. PLoS Genet 16(10): e32767. doi:10.1371/journal.pgen.1009098
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1009098
Summary
The 2,2,7-trimethylguanosine (TMG) cap is one of the first identified modifications on eukaryotic RNAs. TMG, synthesized by the conserved Tgs1 enzyme, is abundantly present on snRNAs essential for pre-mRNA splicing. Results from ex vivo experiments in vertebrate cells suggested that TMG ensures nuclear localization of snRNAs. Functional studies of TMG using tgs1 mutations in unicellular organisms yield results inconsistent with TMG being indispensable for either nuclear import or splicing. Utilizing a hypomorphic tgs1 mutation in Drosophila, we show that TMG reduction impairs germline development by disrupting the processing, particularly of introns with smaller sizes and weaker splice sites. Unexpectedly, loss of TMG does not disrupt snRNAs localization to the nucleus, disputing an essential role of TMG in snRNA transport. Tgs1 loss also leads to defective 3’ processing of snRNAs. Remarkably, stronger tgs1 mutations cause lethality without severely disrupting splicing, likely due to the preponderance of TMG-capped snRNPs. Tgs1, a predominantly nucleolar protein in Drosophila, likely carries out splicing-independent functions indispensable for animal development. Taken together, our results suggest that nuclear import is not a conserved function of TMG. As a distinctive structure on RNA, particularly non-coding RNA, we suggest that TMG prevents spurious interactions detrimental to the function of RNAs that it modifies.
Keywords:
Drosophila melanogaster – Reverse transcriptase-polymerase chain reaction – Larvae – Introns – RNA sequencing – Immunostaining – Small nuclear RNA – Small nucleolar RNA
Introduction
Post-transcriptional modifications have been increasingly recognized as essential for the function of RNA molecules. The 2,2,7-trimethylguanosine modification of the 5’ of RNA molecules (TMG cap) is one of the earliest identified and highly abundant RNA modifications in eukaryotic cells [1]. TMG, which is different from the m7G cap on mRNA molecules, is present on many species of non-coding RNAs such as small nuclear RNA U1, U2, U4 and U5, essential for pre-mRNA splicing (spliceosomal snRNAs) (reviewed in [2–5]), and U7 snRNA, essential for histone RNA processing [6]. It is also present on some of the small nucleolar RNAs (snoRNAs) that function in the processing of ribosomal RNAs [7]. The RNA template for the telomerase enzyme is TMG capped [8], although the molecular function of the cap on this RNA is not entirely clear. Interestingly, TMG cap can also be present on mRNAs. In lower eukaryotes, such as the nematode, chordate and cnidarian, many mRNAs acquire TMG through a trans-splicing reaction between the TMG capped Spliced Leader RNA and the pre-mRNA (reviewed in [9, 10]). In mammals, mRNAs of some of the selenoproteins possess the hypermethylated cap, which might be important for efficient translation of these proteins [11]. TMG has also been shown to promote the expression of viral mRNAs from HIV [12], and the biogenesis of quiescence-induced miRNAs in human cells [13].
Because of the abundance of TMG caps on spliceosomal snRNAs, much discussion on TMG function has been on its possible role in pre-mRNA splicing. Two general approaches have been taken in functional studies of TMG. In the first approach, which was primarily employed in isolated Xenopus eggs and cultured mammalian cells, RNA molecules synthesized or assembled in vitro were made with or without TMG. They were introduced into cells for functional assays. From these studies, it was concluded that TMG is an essential signal for RNA import [14]. Although cell type and snRNA specific requirements for this import signal were later discovered [15–17], it is generally accepted that TMG is at least part of the mechanism controlling nuclear import of snRNAs (reviewed in [5]). Therefore, it is highly expected that the loss of TMG would greatly disrupt splicing as nuclear localization of snRNPs is a fundamental requirement for splicing.
The second approach was to target the enzyme that synthesizes the cap in genetic studies. The Trimethylguanosine Synthase 1 (Tgs1) protein has been shown to be responsible for TMG synthesis [18]. In various organisms, tgs1 mutations led to the loss of TMG. Moreover, conversion of the mono-methylated Guanosine to TMG in vitro requires only Tgs1 that could be supplied as bacterial recombinant proteins [19, 20]. The Tgs1 function appears conserved in eukaryotes as the methylase domain of human Tgs1 can functionally substitute that of Tgs1 from the budding yeast [21].
Genetic studies of tgs1 have been largely limited to unicellular organisms and some of the results are not consistent with conclusions drawn from those in higher eukaryotes using the ex vivo approach. First of all, knock-out mutations of tgs1 are viable in both budding and fission yeasts arguing against a catastrophic defect in pre-mRNA splicing [18, 20], even though they lead to a cold sensitive growth defect and sterility in budding yeast [18, 22]. The sterility is due to defective splicing of a few introns in meiotic specific genes [23]. Therefore, there appears to be a less than anticipated role of TMG in splicing regulation in yeast. Secondly, loss of budding yeast Tgs1/TMG result in the accumulation of U1 snRNAs in the nucleolus not the cytoplasm [18]. Prior results suggest that the maturation of spliceosomal snRNPs in yeast and trypanosomes might not involve snRNA export to the cytoplasm [24–28, however, see 29], whereas snRNA shuttling has been deemed essential in vertebrate cells (for reviews on import factors of snRNAs see [4, 5]). If this organism-specific behavior of snRNA shuttling were indeed important for snRNA function, loss of Tgs1/TMG in higher eukaryotes would be expected to uniquely disrupt the localization of spliceosomal snRNAs and subsequently splicing. Unfortunately, this hypothesis was not tested in previous studies of TMG.
Genetic studies of tgs1 in animals has not been informative in terms of revealing the conserved function of the TMG cap. RNAi knock down of Tgs1 did not affect the proliferation of mammalian cells in culture [30]. Although a tgs1 knock-out mutation in mice led to early embryonic lethality, its effects on pre-mRNA splicing or the integrity and localization of snRNAs were not investigated [31]. In Drosophila, tgs1 mutations support a few days of development before death, most likely due to the preponderance of maternal Tgs1 activities. Although mutant tissues displayed a reduced TMG level, the effect on snRNA localization or splicing was not investigated either [31, 32]. Therefore, although lethality of the mouse and Drosophila tgs1 knock-outs seems to suggest an essential role of Tgs1/TMG that is specific to the development of multi-cellular organisms, it remains undetermined whether nuclear import of RNAs and more generally splicing regulation represent essential functions of the TMG cap in these organisms.
In this study, we characterize new mutations in the Drosophila tgs1 gene and studied their effects on development and on splicing. Although strong loss-of-function mutations led to early lethality, an allelic combination produced viable but infertile flies. This hypomorphic combination has afforded us the unique opportunity of studying Tgs1 in germline development, and we uncovered a prominent role of Tgs1 in splicing. Remarkably, defective splicing in the mutants was not associated with a strong defect in the localization of spliceosomal snRNAs to the nucleus. Nevertheless, we show that TMG might have an important role in regulating the processing of spliceosomal snRNAs.
Materials and methods
Drosophila stocks
Fly stocks and crosses were cultured at 25°C on standard cornmeal food, and w1118 was used as the wide type stock in our study except otherwise noted. The following stocks were obtained from the Bloomington Drosophila Stock Center: moiCB0, and actin5C-gal4 (on chromosome II). The stock for bam-gal4 was a gift from Dr. Xin Chen at Johns Hopkins University (Maryland, USA). The tgs115-11 mutation was generated by us in a previous study [33]. tgs11-3 and tgs12-3 are frameshift mutations generated by Cas-9 mediated mutagenesis described below.
Transgenic constructs and lines
To rescue the tgs1hypo mutant phenotypes, we generated three individual rescuing constructs, shown in S1 Fig, that contain: (1) a genomic fragment with a nucleotide range of 3R:18254530–18258578 based of Flybase releases, which contains the moi/tgs1 coding region and about 1kb up- and 1 kb down-stream of the coding region; (2) a moi cDNA; and (3) a tgs1 cDNA. In the genomic construct, a gfp gene was inserted to the C-terminus of tgs1 coding region generating the tgs1-gfp construct for characterizing the localization of Tgs1 proteins. These fragments were cloned into the pUAST-attB vector and inserted into Drosophila genomic position 75B10 on chromosome III (for genomic rescue constructs) or position 25C on chromosome II (for cDNA rescue constructs) by phi-C31 mediated transformation [34]. The cDNAs were under the control of the UAS elements in the vector, and bam-gal4 and actin-gal4 transgenes were used to drive their expression. PCR primers for plasmid constructions are listed in S1 Table.
Cas-9 mediated mutagenesis of tgs1
We generated new tgs1 alleles with CRISPR-Cas9 mediated mutagenesis using a transgenic approach in which both the Cas9 protein (expressed from a vasa promoter) and gRNA (expressed from a U6 promoter) were produced from transgenes inserted into the Drosophila genome [35]. The target gRNA was designed with an online tool: http://tools.flycrispr.molbio.wisc.edu/targetFinder/. A target sequence about 122bp from the annotated ATG start of tgs1 was chosen that has the sequence of 5’-GAAAGAATTCTGGCAGCGTGAGG with the PAM sequence in bold. Mutations were verified by genomic PCR and sequencing using DNA samples from homozygous mutant larvae.
Fertility and viability testing
Males and females that carry the tgs1hypo heteroallelic combination were individually mated to wildtype animals of the opposite sex. Total progeny was counted and compared with that from crosses using wildtype animals as controls. To test fertility rescue, mutations of tgs1 (in a heterozygous states) were first combined with the rescuing transgene by crosses: either a genomic fragment or a cDNA driven by UAS. The resulting flies were crossed with flies carrying another tgs1 allele and some also with a gal4 driver. Males expressing the wildtypeTgs1 or Moi proteins (either from the genomic clone or from Gal4-driven cDNA expression) were individually mated to wildtype females. Males heterozygous for a tgs1 mutation were used as controls. Fertility of the test males were estimated by us inspecting the number of pupal cases in a vial and determined to be either completely sterile or similar to vials from control males. To test viability rescue, crosses were set up similarly as those for testing fertility. The extent of rescue was determined by counting the progeny carrying both the lethal combination of tgs1 and the rescuing transgene and dividing it over the total progeny. This ratio was then compared with the expected ratio.
Live analyses, Immuno-staining and FISH
For live analyses, testes were dissected in PBS, stained with Hoechst, mounted on slides, lightly squashed, and observed with a 40X objective using phase contrast optics. EdU labelling of testis was performed using the EdU kit from invitrogen per manufacturer’s instruction.
Immunostaining was performed on testes dissected from 1 to 2-day-old flies or tissues from second instar larvae using a standard protocol with a fixative of 3.7% formaldehyde in PBS, and an overnight incubation with a 1:200 dilution of primary antibodies, and a one-hour room temperature incubation with a 1:400 dilution of fluorochrome-conjugated secondary antibodies. Testes were observed with an OLYMPUS confocal microscope. The following primary antibodies were used: mouse anti-2,2,7-Trimethylguanosine monoclonal antibodies (clone K121 from Millipore, and clone 235–1 from MBL), and rabbit anti-phospho-Histone H3 antibody (Sigma, H0412). Each antibody staining experiment was performed at least three times.
FISH analyses on testes and larval tissues were performed with a protocol by Nizami et al. [36]. Fluorescently labelled oligos were used as probes, with their sequences listed in S2 Table.
RNA sequencing, RT-PCR and qPCR
For RNA sequencing and RT-PCR, total RNA was extract from about 100 pairs of testes or 80 second instar larvae using TRIzol reagent (ambion, 15596018). mRNA was enriched by using the NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB,E7490L), then an RNA-Seq library were prepared with the NEBNext Ultra RNA Library Prep Kit for Illumina, the libraries were sequenced with Illumina HiSeq X Ten at Guangzhou IGE Biotechnology Corporation, China. Reverse transcription was performed by PrimeScript RT reagent Kit (TaKaRa, RR047A), and primers for RT-PCR validation of intron retention events are listed in S3 Table.
Quantitative RT-PCR reactions were carried out on a Real-time PCR machine (Lightcycler 480II, Roche), according to a protocol from the KAPA SYBR FAST qPCR Kit (KK4601). Three biological replicates were tested for each sample. The data were calculated by the ΔΔCt method to quantify the differences in expression with rp49 as the reference gene, and the P values were determined with t-tests. The data were plotted as fold changes normalized to wildtype sample. Primer sequences are provided in S3 Table.
To characterize 3’ processing of U snRNAs, a qPCR-based assay was employed as described previously [37], and primers sequences are provided in S3 Table.
Northern blot and RNA Immunoprecipitation
For Northern Blot analyses, 1–5μg of total RNA was denatured at 80°C for 3 min and separated on 5% 8M Urea-polyacrylamide gels in TBE buffer. RNA was transferred to a nylon membrane in TBE buffer at 20V for 30 min, then dried and UV cross-linked for 3 min. The membrane was pre-hybridized in hybridization buffer (25% Formamide, 4XSSC, 50mM NaH2PO4/Na2HPO4 Buffer (PH 7.0), 1mM EDTA, 5% dextran sulfate, 0.5% SDS, 5XDenhard’s solution) at 42°C for 2h and hybridized with 0.1μg /ml of probes in hybridization buffer at 42°C for 16h. The membrane was washed in sequence with 2XSSC (with 0.1% SDS) for 5 min at room temperature, 0.2XSSC (with 0.1% SDS) for 5 min at room temperature, 0.1XSSC (with 0.1% SDS) for 15 min at 60°C, twice for each wash. The snRNA probes were oligonucleotides labeled with biotin. The signals were quantified by Image lab software 5.2 (Biorad). Primer sequences are listed in S2 Table.
For RNA immunoprecipitation, we use the millipore Magna RIP kit (NO.17-700) with TMG specific monoclonal antibody (MBL, 235–1) to precipitate TMG-capped RNA from 20μg of input total RNA, according to manufacturer’s protocol.
Results
A hypomorphic tgs1 mutation disrupts fertility
The Tgs1 protein is encoded by a bicistronic gene in Drosophila in which the telomere-capping protein Modigliani (Moi) and Tgs1 are produced from a single mRNA with the coding region for Moi just upstream of that of Tgs1 (S1A Fig). The loss of either Moi or Tgs1 causes lethality [38,39]. Yet during the course of our investigation into the function of Moi [33], we uncovered a combination of two moi/tgs1 mutant alleles that supports viability but not fertility. Male flies carrying this allelic combination are sterile and females are almost completely sterile (S1B Fig). The molecular lesions of the two alleles are known (moiCB0 and tgs115-11 in S1A Fig). When we used RT-PCR to measure the expression level of moi and tgs1 respectively, we observed similar reductions for both genes (S1C Fig), which is expected given that the two genes share a single transcript.
Due to the complex nature of the two alleles, the simplest way to dissect the relative contributions from moi and tgs1 to the sterility of mutant adults is to introduce rescuing constructs individually providing Moi or Tgs1 function similar to approaches taken by others [38,39]. As shown in S1D Fig, the fertility defects could be rescued with a transgene providing only the Tgs1 function but not one providing Moi alone. We therefore conclude that partial loss of Tgs1 not Moi function was responsible for the impaired fertility in the mutants. Although the allelic combination also represents a partial loss of Moi function as evidenced by RT-PCR results, we hereafter refer this hypomorphic mutation as tgs1hypo for simplicity reason. The genotype of tgs1hypo is moiCB0/tgs115-11.
Partial loss of Tgs1/TMG lead to meiotic arrest in males
Because mutant males are completely sterile while females can produce progeny, we decided to focus this study on the male germline. We discovered that the mutants suffer a classic meiotic arrest phenotype (reviewed in [40, 41]) in that testes were devoid of post-meiotic cells (Fig 1B). Under live phase contrast microscopy, we observed relatively normal morphology of pre-meiotic spermatogonial cells but abnormal meiocytes (Fig 1A, for a details description of different types of male germ cells see [42]). When we labelled cells in divisions using a phospho-H3 antibody, which specifically labels condensed chromosomes, we observed many positive cells in the testicular region where meiosis is happening (Fig 1B). While these cells are tightly clustered in wild type testes, they appear in a scattered pattern in mutant testes (Fig 1B top panels), again consistent with a meiotic defect. This defect was rescued when we drove tgs1, but not moi, expression in the mutant germline using bam-gal4. In contrast, when we labelled cells in S phase with EdU, which gets incorporated into DNA during replication, we did not find clear differences in the localization of replicating cells in mitotic compartments from wild type or mutant testes (Fig 1B bottom panel).
Since Tgs1 is responsible for TMG synthesis, we expected a reduction of TMG level in the mutants and applied two types of measurement of TMG. In the first assay, two commercial anti-TMG antibodies were used in immunostaining of testes. As shown in Fig 2A, the overall level of TMG signals, under the same exposure, is clearly reduced in mutant testes when compared with wild-type or with “tgs1-rescued” but not “moi-rescued” testes. In the second assay, we performed immunoprecipitation (IP) with an anti-TMG antibody to enrich for modified RNA species from total testicular RNA. This was followed by Northern blot detection of U1 and U2 snRNAs, two of the known TMG-containing snRNAs with essential roles in splicing. The U6 snRNA, which lacks TMG, was used as a control. As shown in the top right panels of Fig 3, we observed a severe reduction (40-fold for U1and 20-fold for U2) of TMG in mutant samples again suggesting that the level of TMG is greatly reduced in tgs1hypo mutant testes. Interestingly, the reduction of testicular TMG was evident as early as the third instar stage when we stained larval testes with anti-TMG (Fig 2B), whereas the drop of TMG level was not as evident in other somatic tissues of the same developmental stage suggesting that the male germline might experience a greater loss of TMG when Tgs1 is expressed at a reduced level (S2 Fig). These results are consistent with the ability of mutants to survive into sterile adults, and imply that male germline development might be particularly sensitive to the loss of Tgs1 function.
Introns with smaller sizes and weaker splice sites are preferentially retained in tgs1 mutant testes
The initiation of the male meiotic program has been extensively studied (reviewed in [40, 41]). To gain insights into the underlying cause for the meiotic arrest in tgs1hypo testes, we performed RNA sequencing on total testicular RNA. When expression levels were compared between wild-type and mutant samples, we identified and validated by quantitative PCR a reduction in the level of several key meiotic regulator genes, e.g. mst84da, janB, can (S3 Fig). Importantly, the reductions were rescued with tgs1 but not moi transgenes. In addition, we identified a strong defect in splicing with 2271 introns displaying intron retention (RI in Fig 4, left panel), which was close to 20-fold higher than the level of RI in wild type. The complete list of affected introns is provided in S4 Table and how these introns were identified is provided in S1 Text and S7 Fig. We selected 28 genes identified as having intron retention by the genomics approach (3 from known genes with an important role in spermatogenesis and 25 randomly), and manually validated the splicing defect using RT-PCR in all of them (Fig 5 and S4 Fig). As expected, this splicing defect was rescued with a transgene providing only the Tgs1 but not the Moi function. Therefore, partial loss of Tgs1 function leads to wide-spread intron retention and the meiotic arrest phenotype could be the summed effect from the mis-regulation of a large number of genes, but not just a few of those important for the meiotic program.
Although abnormal splicing in tgs1 mutant testes affected a large number of genes, many introns appeared regularly spliced suggesting that the processing of a class(es) of introns is particularly sensitive to the reduction of Tgs1 function. A similar observation was made in a tgs1 study in yeast [23]. We did not discern an enrichment of a common sequence element around the splice sites of these affected introns arguing against a sequence-specific role of Tgs1/TMG on splicing. To gain further insights, we investigated whether the tgs1-affected introns share common features in size or the strength of splice sites. As controls, we used five groups, 2271 each, of randomly selected introns from the tgs1 non-affected population and performed the same analyses. The information of these selected introns is provided in S5 Table. As shown in Fig 6, introns in the “affected” population have a significantly smaller size, a “weaker” 5 prime or 3 prime splice sites than those from each of the five “non-affected” groups. Therefore, partial loss of Tgs1 function does not affect pre-mRNA splicing indiscriminately.
We also observed an effect of partial loss of Tgs1 on skipped exons (SE). As shown in Fig 4, there appears to be fewer SE events in the mutant than in the wild type. This cause for this drop is not obvious to us.
The effect of losing the TMG cap on spliceosomal snRNAs
Prior investigations have led to the conclusion that TMG is a part of the signal for nuclear import of snRNAs in vertebrate cells. Therefore, we set out to test whether our tgs1 mutation affects the nuclear localization of snRNAs. Using anti-sense probes to U1 and U2 in Fluorescence In-Situ Hybridization (FISH) experiments we localized these snRNAs produced in vivo, and discovered that they are mostly nuclear in both wild-type and tgs1-mutant spermatocytes (Fig 7 and S5A Fig). Interestingly, cytoplasmic puncta of both U1 and U2 became evident in mutant cells, although the cytoplasmic signal represents a minor portion (1.8 arbitrary units of fluorescence on average) when compared with the nuclear signal (65.4 units) (Fig 7). In addition, total U1 and U2 levels were not affected by the tgs1 mutation as shown in the Northern blot of Fig 3 (top left panels). Therefore, tgs1 mutation disrupts splicing without overtly affecting either the total level or the nuclear localization of U1 or U2 snRNAs.
The spliceosomal snRNAs undergo a 3’ processing coupled with their transcription by RNA polymerase II [43, 44, reviewed in 4, 5]. Our results shown later that Tgs1 is primarily a nuclear protein prompted us to examine whether a loss of TMG affects processing, a nuclear event. Using an established qPCR-based method [37], we uncovered processing defects involving essentially all of the TMG-capped spliceosomal snRNAs, as shown in Fig 8B. We also performed Northern blot analyses to further characterize defective processing of U1. As shown in Fig 8C, U1 derivatives larger than the mature species become visible after overexposure of the Northern blot membrane. These larger species were estimated to constitute about 2% of total U1 snRNA. Therefore, a wildtype level of TMG seems to be essential for the initial processing of snRNAs. Since misprocessing happens to a minor portion of the spliceosomal snRNAs, it is unlikely to be the primary cause for the splicing defects in tgs1hypo testes.
The persistent presence of TMG modification reduces splicing defects in lethal tgs1 mutants
It is possible that the function of Tgs1, and that of TMG by extension, affects the processing of most if not all introns, and that the partial disruption of splicing in tgs1hypo testes was the result of the hypomorphic nature of the mutation. This predicts that a stronger tgs1 mutation will have a stronger effect on splicing. We thus generated new frame-shift mutations of tgs1 using CRISPR-mediated mutagenesis (S1 Fig). These mutations (tgs11-3 and tgs12-3) behave as very strong loss-of-function mutations based on their effects on organismal viability (see S1 Text). The tgs12-3 mutation with a 10bp deletion was chosen for all subsequent studies.
We again performed RNA sequencing to investigate whether defects in pre-mRNA splicing are present in mutant animals, which die at the second instar larval stage. To our surprise, bioinformatic analyses identified a much smaller increase of intron retention events from 70 in wt to 203 in the tgs12-3 mutant (RI in Fig 4, right panel). Nor did we detect significant changes in expression level of most genes between the samples.
This lack of a strong splicing defect in the much stronger tgs1 mutants prompted us to investigate the level of TMG. In immunostaining experiments using anti-TMG antibodies, we did not observe an overt drop in TMG level in somatic cells from frameshift mutants (Fig 9). In RNA IP with anti-TMG antibody, we observed a less than 2-fold difference in TMG recovery between the wild-type and mutant samples (bottom right panels in Fig 3). In addition, U1 and U2 are expressed at or near normal level (bottom left panels in Fig 3) and remain nuclear in the lethal mutants (S5B Fig). Remarkably, the 3’ processing defect observed in tgs1hypo mutant testes was also alleviated in tgs12-3 mutant larvae (Fig 8D). These results taken together suggest that the reduction of intron retention in the mutant transcriptome is related to the near normal level of TMG modification. Since that homozygous mutant animals had heterozygous mothers, we suspect that maternal contribution of TMG capped RNA molecules persists into the second instar stage, accounting for the near normal level of TMG in total RNAs. This is conceivable since U snRNPs are remarkably stable complexes [45].
Therefore, the lethality caused by tgs1 frameshift mutations was not the result of wide spread intron retention events. It is possible that it was caused rather by defective splicing of a very few essential genes. To identify possible candidates, we manually annotated the 203 events of intron retention in mutant larvae, which are listed in S6 Table. Using information from flybase (flybase.org), we classified the affected genes as whether they are known essential genes, and whether they have a tissue specific expression pattern. Since many affected genes are known to be essential, we do not favor the hypothesis that loss-of-function due to defective splicing in one or a very few key genes accounts for the lethality. Nor did we identify a clear candidate tissue that was predominantly affected by genes with defective splicing in the mutant.
Tgs1 is primarily a nuclear protein with an enrichment at the nucleolus
The cellular localization of Tgs1 proteins seems to differ among different organisms, with a primarily nuclear localization reported for yeast [18], Trypanosoma [46], Plasmodium [47], transfected mammalian cells [48], and simultaneous cytoplasmic and nuclear localizations of human Tgs1 [49, 50]. Interestingly, nucleolar enrichment has been reported for the yeast protein [51].
Absent of a Tgs1 antibody, we used a gfp-tagged tgs1 transgene in the investigation of Tgs1 localization in Drosophila cells. To ensure that in vivo localization of Tgs1-GFP accurately reflects that of the endogenous Tgs1 protein, we carried out an extensive analysis on how well the tgs1-gfp transgene rescues the various defects displayed by hypomorphic and lethal tgs1 mutations. Results from this analysis are shown in S7 Table and S6 Fig. At the organismal level, tgs1-gfp fully rescued male fertility to tgs1hypo animals, and viability to tgs12-3 animals (S7 Table). At the cellular level, tgs1-gfp restored TMG level and 3’ processing of U1 to the wildtype level in the testis (S6A Fig and Fig 8C). Finally, at the molecular level, tgs1-gfp restored normal splicing to genes that were affected by tgs1hypo (S6B Fig). Therefore, we are confident that Tgs1-GFP would share very similar if not identical distribution pattern with Tgs1 proteins produced from its endogenous locus.
We discovered that Tgs1 is kept at a low level in that GFP fluorescence was not discernably higher than background fluorescence in diploid cells. Nevertheless, it is visible in polyploid cells such as those in salivary glands and fat body of third instar larvae, and follicle and nurse cells in adult ovaries. In these polyploid cells, Tgs1-GFP is primarily nuclear and enriched in the nucleolus, which can be marked with the nucleolar Fibrillarin (Fib) protein (Fig 10). Therefore, Drosophila Tgs1 appears primarily a nuclear protein with an enrichment at the nucleolus in polyploid cells. However, our live analysis cannot rule out the presence of a low level of Tgs1-GFP in the cytoplasm.
Discussion
TMG capping of RNAs represents a conserved and prevalent modification in eukaryotic organisms. Yet prior studies pointed to the possibility that additional functions of the TMG cap exist that are specific for multicellular organisms since the loss of Tgs1, the enzyme solely responsible for synthesizing TMG, does not support life in mice or flies. Here we conducted a developmental study of tgs1 in the genetically tractable model of Drosophila. Although our results are consistence with the loss of TMG having a more severe effect on pre-mRNA splicing in complex organisms, they also revealed that the lethality of tgs1 mutants needs not be accompanied by a strong defect in splicing. In addition, strong reduction of TMG disrupts splicing in the germline without entailing a similar effect on the nuclear retention of spliceosomal snRNAs. Interestingly, partial loss of TMG affects transcription-coupled processing of snRNAs. These findings suggest major modifications to the current understanding of the molecular function of TMG.
A previously untested hypothesis for the role of TMG cap in splicing regulation
The abundance of TMG on spliceosomal snRNAs justifies the significant prior effort on investigating its role in splicing regulation. In a large body of work on splicing reconstitution, in vitro synthesized snRNAs without the TMG cap were used successfully in various steps of the splicing reaction [e.g. 52–56]. In fact, the requirement of TMG for the in vitro formation of splicing complexes was specifically tested in as least one study from which the same conclusion as above was drawn [57]. This argues strongly that TMG is not part of the structural element on spliceosomal snRNAs intrinsically required for the biochemistry of pre-mRNA splicing. Nevertheless, a large body of work in vertebrate cells led to the conclusion that TMG is a part of the signal directing the nuclear import of spliceosomal snRNAs (reviewed in [4, 5]). Since spliceosomal snRNP maturation requires a cytoplasmic step in higher eukaryotes but not fungi, this molecular function of TMG offers a logical reconciliation between the general lack of growth defect in yeast tgs1 mutants and the indispensable role of TMG for the development of mice and flies. However, this assumes that the cause of death in mouse and fly tgs1 mutants is related to splicing. This hypothesis remains untested before our study.
Possible causes for defective splicing upon TMG loss
We showed that a strong reduction of TMG level on spliceosomal snRNAs had a great impact on splicing in Drosophila testis. However, we also showed that this loss of splicing efficiency does not have to involve a disruption of the nuclear localization of spliceosomal snRNAs. Since the levels of spliceosomal snRNAs in the mutant testes remain normal, the strong reduction of TMG in mutant testes argues that a significant portion of the snRNAs in the nucleus lack the TMG cap. In addition, a significant portion of spliceosomal snRNAs in the mutant nuclei must not have been functional based on the splicing defects that we observed. How much of these two populations overlaps required additional investigation. In a previous study of human Tgs1 [30], RNAi-mediated reduction of Tgs1 to a level less than 10% of the normal one did not cause a discernable accumulation of U2 or U4 in the cytoplasm. These results would have been consistent with what we observed in flies, suggesting TMG is not needed for nuclear transport. Unfortunately, the endogenous TMG level was not determined in the human study and therefore it could not be ruled out that the exclusive nuclear localization of U2 and U4 in tgs1 knock-down human cells was due to the persistent presence of the TMG cap on those snRNAs.
It is possible that the maturation of spliceosomal snRNAs does not requires a cytoplasmic step in Drosophila as the case in yeast and Trypanosomes. We consider this unlikely as all members of the machinery important for snRNA shuttling have fly homologs (reviewed in [4]), even though species specific feature of the import exists in Drosophila [58]. In addition, spliceosomal complexes in human and flies share highly similar protein composition and ultra-structure [59]. Another pathway controlled by the Sm-core proteins has been shown to mediate snRNA nuclear import independent of the TMG cap (reviewed in [4, 5]). Prior evidence suggests that such pathway is functional in Drosophila [58]. To help determining whether nuclear U1 and U2 in tgs1hypo testes are indeed transported via this pathway requires genetic manipulations in which core components of the pathway are also knocked out in the mutant testes.
On the possible cause for defective splicing upon TMG loss, we speculate that it is the reduction of the effective concentration of functional snRNPs, which could be due to the gain of one or more abnormal interactions as a result of missing the TMG cap. Our proposition resonates with what have been observed in tgs1 mutants in the budding yeast [22]. Through extensive proteomics analyses, it was discovered that TMG-less U1 acquires an ectopic interaction with the nuclear Cap Binding Complex (CBP). Remarkably, this ectopic interaction likely causes the cold-sensitive growth defect in tgs1 mutants as a mutation in CBP that weakens the ectopic interaction rescues the cold-sensitive phenotype. Since the ectopic CBP-U1 interaction was discovered by immunoprecipitating protein components of the normal U1 RNP, additional ectopic interactions might have been missed in the yeast study, that might involve TMG-less snRNAs with factors that are not normal components of the snRNPs. Hazardous interactions similar in nature might be the underlying cause for the splicing abnormality that we observed in tgs1 mutant flies. These interactions might reduce the effective concentration of functional snRNPs so that introns that are more difficult to splice might be at a disadvantage when competing for spliceosomal snRNPs. The cytoplasmic puncta that appear in mutant testicular cells might also be the result of such spurious interactions, further reducing the level of functional snRNPs.
It is surprising that 3’ processing of some of the spliceosomal snRNAs is defective in tgs1hypo testis. The processing of these snRNAs has been shown to be coupled with transcription and therefore represents one of the earliest steps in snRNA biogenesis (reviewed in [4], [5]). TMG capping, on the other hand, is believed to be entirely cytoplasmic in higher eukaryotes and the last modification happened to snRNAs. We consider it unlikely that this effect of Tgs1 partial loss-of-function on snRNA 3’ processing is independent of Tgs1’s function in TMG synthesis. Since larvae carrying stronger tgs1 mutations displayed normal snRNA processing accompanied by normal levels of TMG, we suggest that defective processing is likely linked to the loss of TMG. We considered the possibility that defective processing was an indirect effect of defective splicing affecting factors important for processing. The Integrator complex plays an essential role in 3’ processing of snRNAs (reviewed in [4, 5, 37]). However, we discovered that genes for subunits of the complex are not present in the list of genes whose splicing was disrupted in tgs1 mutants. Therefore, evidence supporting an indirect effect remains absent. This interconnection that we uncovered between two events supposedly separated in time and space represents another reminder that the complexity of TMG function is far from being understood.
The universal function of TMG as a regulator of RNA-protein interaction
As one searches for the fundamentally conserved function of TMG, one needs to consider other cases in which TMG plays an important biological role. The biological phenomenon of trans-splicing is another case in which much effort has been spent on elucidating the function of the TMG cap (reviewed in [9]). In many organisms, including the model worm C. elegans, a significant portion of the mRNA molecules acquire a 5’ TMG cap via a trans-splicing reaction involving the Spliced Leader (SL) RNA that is capped with TMG. At least one of the functions of this mode of trans-splicing is to facilitate the maturation of mRNA molecules from poly-cistronic genes in eukaryotes. Nevertheless, the SL leader itself is non-coding and has features, including secondary structure and the binding of SM proteins, that are similar to those of U snRNAs [10]. The fact that SL RNAs in many of the parasitic organisms is not TMG capped suggests that TMG is not a feature essential for trans-splicing per se. It is known that cap binding complexes for translation discriminate between m7G and TMG caps [60]. Elegant biochemical and structural studies revealed that the TMG cap, together with specific segment of the SL RNA ensure efficient translation of SL-spliced mRNAs [61]. Therefore, in the case of trans-splicing, TMG mediates the interaction with the translational machinery.
It is interesting that TMG capped RNAs are overwhelmingly non-coding: snRNAs, SL RNA, snoRNA, the RNA template for the telomerase enzyme, and miRNAs. We speculate that TMG serves to regulate the interaction between non-coding RNAs and the proteins important for their functions. Such regulations can be positive, as in the case of translation of SL-spliced mRNA, and in the case of snRNA nuclear import in which TMG is specifically recognized by the Snurporin 1 protein [62]. Such regulations can also be inhibitory in nature, as in the case of preventing ectopic interaction involving spliceosomal snRNAs in yeast [22] and possibly in flies (this study).
It is interesting that the U7 snRNA in Drosophila and U2.3 snRNA in Arabidopsis, although themselves being non-coding, permits translation of a downstream reporter gene in hybrid transcripts where the snRNA essentially serves as a 5’ UTR [37, 63]. Therefore, it is possible that the TMG cap prevents normal snRNAs from being recognized as peptide-encoding, the failure of which would have grave consequences giving the large amount of snRNAs in the cell.
Tgs1’s essential role in animal development and its relationship with pre-mRNA splicing
The early lethality of animals homozygous for our loss-of-function tgs1 mutations seems at odds with RNA sequencing results showing little defect in pre-mRNA splicing. The substantial TMG level present in those animals provides a plausible explanation. There has not been a de-capping enzyme identified that removes TMG. Therefore, the life of TMG could be as long as the RNA that they cap. It has been shown that U snRNPs could have half-lives up to five days in mammalian cells [45]. This extreme stability of U snRNPs coupled with the preponderance of maternal supply of Tgs1 activity could maintain a substantial level of TMG in second instar tgs1-mutant larvae. This in turn ensures proper splicing and normal snRNA processing to proceed.
It is possible that defective splicing of a very few critical genes is sufficient for organismal death. However, this was not supported by our functional annotation of the affected genes identified by RNA seq. It is also possible that the lethality was the accumulative effect of defective splicing of multiple genes. Alternatively, the cause for lethality could be the functional disruption of one or more less abundant TMG-capped RNA molecules, independent of pre-mRNA splicing. Without TMG, such transcripts might become unstable or engage in other interactions deleterious to its function. A systematic identification of other TMG-capped RNAs, similar to what has been done in C. elegans [64], is required for a better understanding of Tgs1 function in development. Our tgs1 mutations would facilitate functional validation of any such TMG-capped RNAs identified.
Supporting information
S1 Text [docx]
Supplemental methods and Data.
S1 Fig [top]
mutant alleles and their organismal phenotypes.
S2 Fig [tif]
TMG levels in somatic tissues of tgs1hypo larvae.
S3 Fig [tif]
Loss of Tgs1 disrupts gene expression in the testes.
S4 Fig [tif]
Validation of additional intron retention events in tgs1hypo testes.
S5 Fig [white]
FISH analyses of U1 and U2 localization in testes and larval tissues.
S6 Fig [wt]
Tgs1-GFP carries normal Tgs1 functions.
S7 Fig [grey]
Graphical description of bioinformatic analyses of splicing events.
S1 Table [docx]
List of primers used for making the rescue constructs.
S2 Table [docx]
List of snRNA probes for Northern blots and FISH.
S3 Table [docx]
List of primers used for qPCR and RT-PCR.
S4 Table [xlsx]
The complete list of the 2271 introns affected in tgs1hypo testes.
S5 Table [xlsx]
The complete list of the five groups of randomly selected “control” introns used in .
S6 Table [xlsx]
The list of defective introns from larvae RNA seq experiments.
S7 Table [docx]
Tgs1-GFP fully rescues the lethal and sterile phenotypes of tgs1 mutations.
S1 Data [xlsx]
Numerical data for .
S2 Data [xlsx]
Numerical data for .
S3 Data [xlsx]
Numerical data for .
S4 Data [xlsx]
Numerical data for .
Zdroje
1. Saponara AG, Enger MD. Occurrence of N2, N2, 7-trimethylguanosine in minor RNA species of a mammalian cell line. Nature. 1969; 223(5213): 1365–1366. doi: 10.1038/2231365a0 5817758
2. Busch H, Reddy R, Rothblum L, Choi YC. SnRNAs, SnRNPs, and RNA processing. Annu Rev Biochem, 1982; 51: 617–654. doi: 10.1146/annurev.bi.51.070182.003153 6180681
3. Reddy R, Henning D, Busch H. Primary and secondary structure of U8 small nuclear RNA. J Biol Chem. 1985; 260(20): 10930–10935. 2411727
4. Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol. 2007; 8(3): 209–220. doi: 10.1038/nrm2124 17318225
5. Fischer U, Englbrecht C, Chari A. Biogenesis of spliceosomal small nuclear ribonucleoproteins. Wiley Interdiscip Rev RNA. 2011; 2(5): 718–731. doi: 10.1002/wrna.87 21823231
6. Godfrey AC, Kupsco JM, Burch BD, Zimmerman RM, Dominski Z, Marzluff WF, et al. U7 snRNA mutations in Drosophila block histone pre-mRNA processing and disrupt oogenesis. Rna. 2006; 12(3): 396–409. doi: 10.1261/rna.2270406 16495235
7. Terns MP, Dahlberg JE. Retention and 5'cap trimethylation of U3 snRNA in the nucleus. Science. 1994; 264 (5161): 959–961. doi: 10.1126/science.8178154 8178154
8. Franke J, Gehlen J, Ehrenhofer-Murray AE. Hypermethylation of yeast telomerase RNA by the snRNA and snoRNA methyltransferase Tgs1. J Cell Sci. 2008; 121(21): 3553–3560.
9. Lasda EL, Blumenthal T. Trans-splicing. Wiley Interdiscip Rev RNA. 2011; 2(3): 417–434. doi: 10.1002/wrna.71 21957027
10. Krchňáková Z, Krajčovič J, Vesteg M. On the possibility of an early evolutionary origin for the spliced leader Trans-Splicing. J Mol Evol. 2017; 85(1–2): 37–45. doi: 10.1007/s00239-017-9803-y 28744787
11. Wurth L, Gribling-Burrer AS, Verheggen C, Leichter M, Takeuchi A, Baudrey S, et al. Hypermethylated-capped selenoprotein mRNAs in mammals. Nucleic Acids Res. 2014; 42(13): 8663–8677. doi: 10.1093/nar/gku580 25013170
12. Yedavalli VS, Jeang KT. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A. 2010; 107(33): 14787–14792. doi: 10.1073/pnas.1009490107 20679221
13. Martinez I, Hayes KE, Barr JA, Harold AD, Xie M, Bukhari SI, et al. An Exportin-1-dependent microRNA biogenesis pathway during human cell quiescence. Proc Natl Acad Sci U S A. 2017; 114(25): E4961–E4970. doi: 10.1073/pnas.1618732114 28584122
14. Fischer U, Lührmann R. An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus. Science. 1990; 249 (4970): 786–790. doi: 10.1126/science.2143847 2143847
15. Hamm J, Darzynkiewicz E, Tahara SM, Mattaj IW. The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal. Cell, 1990; 62(3): 569–577. doi: 10.1016/0092-8674(90)90021-6 2143105
16. Fischer U, Darzynkiewicz E, Tahara SM, Dathan NA, Lührmann R, Mattaj IW. Diversity in the signals required for nuclear accumulation of U snRNPs and variety in the pathways of nuclear transport. J Cell Biol. 1991; 113(4): 705–714. doi: 10.1083/jcb.113.4.705 1827444
17. Fischer U, Heinrich J, Van Zee K, Fanning E, Lührmann R. Nuclear transport of U1 snRNP in somatic cells: differences in signal requirement compared with Xenopus laevis oocytes. J Cell Biol. 1994; 125(5): 971–980 doi: 10.1083/jcb.125.5.971 8195300
18. Mouaikel J, Verheggen C, Bertrand E, Tazi J, Bordonné R. Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is localized to the nucleolus. Mol Cell. 2002; 9(4): 891–901. doi: 10.1016/s1097-2765(02)00484-7 11983179
19. Hausmann S, Shuman S. Specificity and mechanism of RNA cap guanine-N2 methyltransferase (Tgs1). J Biol Chem, 2005; 280(6): 4021–4024. doi: 10.1074/jbc.C400554200 15590684
20. Hausmann S, Ramirez A, Schneider S, Schwer B, Shuman S. Biochemical and genetic analysis of RNA cap guanine-N2 methyltransferases from Giardia lamblia and Schizosaccharomyces pombe. Nucleic Acids Res. 2007; 35(5): 1411–1420. doi: 10.1093/nar/gkl1150 17284461
21. Hausmann S, Zheng S, Costanzo M, Brost RL, Garcin D, Boone C, et al. Genetic and biochemical analysis of yeast and human cap trimethylguanosine synthase: functional overlap of 2,2,7-trimethylguanosine caps, small nuclear ribonucleoprotein components, pre-mRNA splicing factors, and RNA decay pathways. J Biol Chem. 2008; 283(46): 31706–31718. doi: 10.1074/jbc.M806127200 18775984
22. Schwer B, Erdjument-Bromage H, Shuman S. Composition of yeast snRNPs and snoRNPs in the absence of trimethylguanosine caps reveals nuclear cap binding protein as a gained U1 component implicated in the cold-sensitivity of tgs1 Δ cells. Nucleic Acids Res. 2011; 39(15): 6715–6728. doi: 10.1093/nar/gkr279 21558325
23. Qiu ZR, Shuman S, Schwer B. An essential role for trimethylguanosine RNA caps in Saccharomyces cerevisiae meiosis and their requirement for splicing of SAE3 and PCH2 meiotic pre-mRNAs. Nucleic Acids Res. 2011; 39(13): 5633–5646. doi: 10.1093/nar/gkr083 21398639
24. Murphy MW, Olson BL, Siliciano PG. The yeast splicing factor Prp40p contains functional leucine-rich nuclear export signals that are essential for splicing. Genetics. 2004; 166(1): 53–65. doi: 10.1534/genetics.166.1.53 15020406
25. Boon KL, Grainger RJ, Ehsani P, Barrass JD, Auchynnikava T, Inglehearn CF, et al. prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast. Nat Struct Mol Biol. 2007; 14(11): 1077–1083. doi: 10.1038/nsmb1303 17934474
26. Tkacz ID, Lustig Y, Stern MZ, Biton M, Salmon-Divon M, Das A, et al. Identification of novel snRNA-specific Sm proteins that bind selectively to U2 and U4 snRNAs in Trypanosoma brucei. RNA. 2007; 13(1): 30–43. doi: 10.1261/rna.174307 17105994
27. Palfi Z, Jaé N, Preusser C, Kaminska KH, Bujnicki JM, Lee JH, et al. SMN-assisted assembly of snRNPspecific Sm cores in trypanosomes. Genes Dev. 2009. 23(14): 1650–1664. doi: 10.1101/gad.526109 19605687
28. Jaé N, Preusser C, Krüger T, Tkacz ID, Engstler M, Michaeli S, et al. snRNA-specific role of SMN in trypanosome snRNP biogenesis in vivo. RNA Biol. 2011; 8(1): 90–100. doi: 10.4161/rna.8.1.13985 21282982
29. Becker D, Hirsch AG, Bender L, Lingner T, Salinas G, Krebber H. Nuclear Pre-snRNA Export Is an Essential Quality Assurance Mechanism for Functional Spliceosomes. Cell Rep. 2019; 27(11): 3199–3214. doi: 10.1016/j.celrep.2019.05.031 31189105
30. Lemm I, Girard C, Kuhn AN, Watkins NJ, Schneider M, Bordonné R, et al. Ongoing U snRNP biogenesis is required for the integrity of Cajal bodies. Mol Biol Cell. 2006; 17(7): 3221–3231. doi: 10.1091/mbc.e06-03-0247 16687569
31. Jia Y, Viswakarma N, Crawford SE, Sarkar J, Rao MS, Karpus WJ, et al. Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene. Mech Dev. 2012; 129(9–12): 193–207. doi: 10.1016/j.mod.2012.08.002 22982455
32. Komonyi O, Pápai G, Enunlu I, Muratoglu S, Pankotai T, Kopitova D, et al. DTL, the Drosophila homolog of PIMT/Tgs1 nuclear receptor coactivator interacting protein/RNA methyltransferase, has an essential role in development. J Biol Chem. 2009; 280(13): 12397–12404.
33. Zhang Y, Zhang L, Tang X, Bhardwaj SR, Ji J, Rong YS. MTV, an ssDNA protecting complex essential for transposon-based telomere maintenance in Drosophila. PLoS Genet. 2016; 12(11): e1006435. doi: 10.1371/journal.pgen.1006435 27835648
34. Bischof J, Maeda RK, Hediger M, Karch F, Basler K. An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases. Proc Natl Acad Sci U S A. 2007; 104(9): 3312–3317. doi: 10.1073/pnas.0611511104 17360644
35. Port F, Chen HM, Lee T, Bullock SL. Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci U S A. 2014; 111(29): E2967–E2976. doi: 10.1073/pnas.1405500111 25002478
36. Nizami ZF, Liu JL, Gall JG. Fluorescent In Situ Hybridization of Nuclear Bodies in Drosophila melanogaster Ovaries. Methods Mol Biol. 2015; 1328: 137–149. doi: 10.1007/978-1-4939-2851-4_10 26324435
37. Ezzeddine N, Chen J, Waltenspiel B, Burch B, Albrecht T, Zhuo M, et al. A subset of Drosophila integrator proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3′-end formation. Mol Cell Biol. 2011; 31(2): 328–341. doi: 10.1128/MCB.00943-10 21078872
38. Raffa GD, Siriaco G, Cugusi S, Ciapponi L, Cenci G, Wojcik E, et al. The Drosophila modigliani (moi) gene encodes a HOAP interacting protein required for telomere protection. Proc Natl Acad Sci U S A. 2009; 106(7): 2271–2276. doi: 10.1073/pnas.0812702106 19181850
39. Komonyi O, Schauer T, Papai G, Deak P, Boros IM. A product of the bicistronic Drosophila melanogaster gene CG31241, which also encodes a trimethylguanosine synthase, plays a role in telomere protection. J Cell Sci. 2009; 122(6): 769–774.
40. Fuller MT. Genetic control of cell proliferation and differentiation in Drosophila spermatogenesis. Semin Cell Dev Biol. 1998; 9(4): 433–444. doi: 10.1006/scdb.1998.0227 9813190
41. White-Cooper H. Molecular mechanisms of gene regulation during Drosophila spermatogenesis. Reproduction. 2010; 139(1): 11–21. doi: 10.1530/REP-09-0083 19755484
42. Cenci G, Bonaccorsi S, Pisano C, Verni F, Gatti M. Chromatin and microtubule organization during premeiotic, meiotic and early postmeiotic stages of Drosophila melanogaster spermatogenesis. J Cell Sci. 1994; 107(12): 3521–3534.
43. Hernandez N, Weiner AM. Formation of the 3' end of U1 snRNA requires compatible snRNA promoter elements. Cell. 1986; 47(2): 249–258. doi: 10.1016/0092-8674(86)90447-2 3768956
44. de Vegvar HE, Lund E, Dahlberg JE. 3' end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell. 1986; 47(2): 259–266. doi: 10.1016/0092-8674(86)90448-4 3021336
45. Sauterer RA, Feeney RJ, Zieve GW. Cytoplasmic assembly of snRNP particles from stored proteins and newly transcribed snRNA's in L929 mouse fibroblasts. Exp Cell Res. 1988; 176(2): 344–359. doi: 10.1016/0014-4827(88)90336-9 2967772
46. Ruan JP, Ullu E, Tschudi C. Characterization of the Trypanosoma brucei cap hypermethylase Tgs1. Mol Biochem Parasitol. 2007; 155(1): 66–69. doi: 10.1016/j.molbiopara.2007.05.008 17610965
47. Babar PH, Dey V, Jaiswar P, Patankar S. An insertion in the methyltransferase domain of P. falciparum trimethylguanosine synthase harbors a classical nuclear localization signal. Mol Biochem Parasitol. 2016; 210(1–2): 58–70. doi: 10.1016/j.molbiopara.2016.08.007 27619053
48. Zhu Y, Qi C, Cao WQ, Yeldandi AV, Rao MS, Reddy JK. Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function. Proc Natl Acad Sci U S A. 2001; 98(18): 10380–10385. doi: 10.1073/pnas.181347498 11517327
49. Enünlü I, Pápai G, Cserpán I, Udvardy A, Jeang KT, Boros I. Different isoforms of PRIP-interacting protein with methyltransferase domain/trimethylguanosine synthase localizes to the cytoplasm and nucleus. Biochem Biophys Res Commun. 2003; 309(1): 44–51. doi: 10.1016/s0006-291x(03)01514-6 12943661
50. Mouaikel J, Narayanan U, Verheggen C, Matera AG, Bertrand E, Tazi J, et al. Interaction between the small-nuclear-RNA cap hypermethylase and the spinal muscular atrophy protein, survival of motor neuron. EMBO Rep. 2003; 4(6): 616–622. doi: 10.1038/sj.embor.embor863 12776181
51. Mouaikel J, Bujnicki JM, Tazi J, Bordonné R. Sequence–structure function relationships of Tgs1, the yeast snRNA/snoRNA cap hypermethylase. Nucleic Acids Res. 2003; 31(16): 4899–4909. doi: 10.1093/nar/gkg656 12907733
52. Patton JR, Patterson RJ, Pederson T. Reconstitution of the U1 small nuclear ribonucleoprotein particle. Mol Cell Biol. 1987; 7(11): 4030–4037. doi: 10.1128/mcb.7.11.4030 2963210
53. Siegall CB, Hla TT, Kumar A. Reconstituted U1 small nuclear ribonucleoprotein complex restores 5′splice site cleavage activity. Biochem Biophys Res Commun. 1988; 154(3): 1010–1017. doi: 10.1016/0006-291x(88)90240-9 2970258
54. McPheeters DS, Fabrizio P, Abelson J. In vitro reconstitution of functional yeast U2 snRNPs. Genes Dev. 1989; 3(12b): 2124–2136. doi: 10.1101/gad.3.12b.2124 2560754
55. Wersig C, Bindereif A. Reconstitution of functional mammalian U4 small nuclear ribonucleoprotein: Sm protein binding is not essential for splicing in vitro. Mol Cell Biol. 1992; 12(4): 1460–1468. doi: 10.1128/mcb.12.4.1460 1532228
56. Ségault V, Will CL, Sproat BS, Lührmann R. In vitro reconstitution of mammalian U2 and U5 snRNPs active in splicing: Sm proteins are functionally interchangeable and are essential for the formation of functional U2 and U5 snRNPs. EMBO J. 1995; 14(16): 4010–4021. 7664740
57. Dönmez G, Hartmuth K, Lührmann R. Modified nucleotides at the 5′ end of human U2 snRNA are required for spliceosomal E-complex formation. Rna, 2004; 10(12): 1925–1933. doi: 10.1261/rna.7186504 15525712
58. Natalizio AH, Matera AG. Identification and characterization of Drosophila Snurportin reveals a role for the import receptor Moleskin/importin 7 in snRNP biogenesis. Mol Biol Cell. 2013; 24(18): 2932–2942. doi: 10.1091/mbc.E13-03-0118 23885126
59. Herold N, Will CL, Wolf E, Kastner B, Urlaub H, Lührmann R. Conservation of the protein composition and electron microscopy structure of Drosophila melanogaster and human spliceosomal complexes. Mol Cell Biol. 2009; 29(1): 281–301. doi: 10.1128/MCB.01415-08 18981222
60. Liu W, Zhao R, McFarland C, Kieft J, Niedzwiecka A, Jankowska-Anyszka M, et al. Structural insights into parasite eIF4E binding specificity for m7G and m2,2,7G mRNA caps. J Biol Chem. 2009; 284(45): 31336–31349. doi: 10.1074/jbc.M109.049858 19710013
61. Liu W, Jankowska-Anyszka M, Piecyk K, Dickson L, Wallace A, Niedzwiecka A, et al. Structural basis for nematode eIF4E binding an m(2,2,7)G-Cap and its implications for translation initiation. Nucleic Acids Res. 2011; 39(20): 8820–8832. doi: 10.1093/nar/gkr650 21965542
62. Strasser A, Dickmanns A, Lührmann R, Ficner R. Structural basis for m3G-cap-mediated nuclear import of spliceosomal UsnRNPs by snurportin1. EMBO J. 2005; 24(13): 2235–2243. doi: 10.1038/sj.emboj.7600701 15920472
63. Liu Y, Li S, Chen Y, Kimberlin AN, Cahoon EB, Yu, B. snRNA 3' End Processing by a CPSF73-Containing Complex Essential for Development in Arabidopsis. PLoS Biol. 2016; 14(10): e1002571. doi: 10.1371/journal.pbio.1002571 27780203
64. Jia D, Cai L, He H, Skogerbø G, Li T, Aftab MN, et al. Systematic identification of non-coding RNA 2, 2, 7-trimethylguanosine cap structures in Caenorhabditis elegans. BMC Mol Biol. 2007; 8(1): 86.
Článek vyšel v časopise
PLOS Genetics
2020 Číslo 10
- Prof. Libor Grubhoffer: Nová varianta mpox je příležitostí pokročit v poznání původce varioly
- Co obsahují nové pokyny WHO pro dozor nad antibiotickou rezistencí?
- AI místo lékaře? Výzkum zkoumal ochotu Čechů konzultovat své zdraví s umělou inteligencí
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
Nejčtenější v tomto čísle
- Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies
- RNA-directed DNA Methylation
- The DNA methylome of human sperm is distinct from blood with little evidence for tissue-consistent obesity associations
- Correction: Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma